Abhishek Bhat, MD

Articles by Abhishek Bhat, MD

Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

ByAbhishek Bhat, MD,Sanoj Punnen, MD, MAS

June 19th 2019

In this Point/Counterpoint, Drs. Bhat and Punnen argue that active surveillance can be beneficial for patients with intermediate-risk prostate cancer.

Latest Updated Articles

Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?
June 19th 2019

Abhishek Bhat, MD

Articles by Abhishek Bhat, MD

Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

Latest Updated Articles

Trending on CancerNetwork

Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC

FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma

The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes

Selinexor Combo Improves Spleen Volume Reduction in Myelofibrosis

Considering Venlafaxine as Distress Treatment in Breast Cancer